-+ 0.00%
-+ 0.00%
-+ 0.00%

NEKTAR THERAPEUTICS : LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $130

Reuters·10/12/2026 10:14:37

Please log in to view news